Oscar Health Inc. (OSCR) Tops Q4 EPS by 9c

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($1.05), $0.09 better than the analyst estimate of ($1.14). Revenue for the quarter came in at $995 million versus the consensus estimate of $1.18 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks
• Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold